Erika Mendelsohn

Suggest Changes
Learn More
Comorbid schizophrenia and dementia is becoming an increasingly common phenomenon. Because rivastigmine, a reversible acetylcholinesterase inhibitor, appears to delay the progression of Alzheimer's(More)
  • 1